GMF Capital

GMF Capital LLC is a private equity firm established in 2013, headquartered in New York, with additional offices in Baltimore and Wollerau, Switzerland. The firm specializes in private equity and alternative investments, focusing primarily on the real estate and healthcare sectors, as well as structured credit. GMF Capital employs a management platform that leverages its extensive experience and a proprietary network of relationships to identify and execute investment opportunities. The firm aims to achieve superior risk-adjusted returns through cash-flowing investments that emphasize liquidity and exhibit limited exposure to cyclical volatility.

Gary Fegel

Founder

6 past transactions

Motorsport Network

Acquisition in 2023
Motorsport Network is a prominent multinational company specializing in multimedia and technology within the automotive and motorsport sectors. It operates a global digital media and technology platform that provides a range of digital assets, including exclusive video content and the largest image library dedicated to motorsports and automotive themes. The company enhances user experiences through its diverse offerings in digital media, gaming, eSports, and event management, making it a significant player in the industry. Its focus on data and statistics further supports its mission to connect enthusiasts and audiences worldwide, providing valuable resources and engagement opportunities within the motorsport community.

sMiles

Seed Round in 2022
sMiles is a platform that enables users to earn Bitcoin through everyday activities such as walking, shopping, playing games, and completing surveys. It employs a gamified approach to incentivize user engagement, rewarding participants with fractional Bitcoin for their activities. By utilizing network technology and a backend system designed for micro-incentives, sMiles connects location sponsors with users, allowing advertisers to allocate budgets directly to individuals. This strategy not only fosters customer loyalty but also encourages users to participate in their daily routines while earning cryptocurrency.

Pardes Biosciences

Post in 2021
Pardes Biosciences is a clinical-stage biopharmaceutical company focused on addressing significant health challenges, particularly those posed by viral infections. It utilizes modern reversible-covalent chemistry to discover and develop novel oral drug candidates. The company's lead product candidate, PBI-0451, is an oral antiviral designed to treat and prevent infections from SARS-CoV-2, the virus responsible for COVID-19. By reimagining the patient journey, Pardes aims to provide accessible and convenient treatment options for both adult and pediatric patients, ultimately striving to improve health outcomes and respond effectively to global health crises.

My Sky

Funding Round in 2020
My Sky SA specializes in developing a spend management platform tailored for the aviation industry, offering solutions designed for asset managers, asset owners, and corporate flight departments. Founded in 2016 and headquartered in Lausanne, Switzerland, with additional offices in New York and Moscow, the company provides automated financial and accounting processes, enhancing transparency and independent verification for jet owners. Its innovative platform digitizes, verifies, analyzes, and stores financial information, ensuring instant access to critical data. My Sky's commitment to Swiss standards of efficiency and data security underscores its independence from market influences, allowing it to focus on optimizing asset management for business aircraft owners. Since its public launch in 2015, My Sky has gained recognition in Europe and the CIS, receiving several prestigious awards for its contributions to the aviation sector. With a team of over 80 experts, including auditors and IT specialists, My Sky aims to revolutionize jet ownership through technology and expertise, while steadily expanding its global presence in the business aviation market.

InterCure

Post in 2018
InterCure Ltd. is a medical device company that specializes in the development of innovative technologies for the treatment of cardiovascular and pulmonary diseases. Founded in 1994 and based in Hadera, Israel, InterCure has created a patented technology platform known as "Interactive Respiratory-Pacing." This platform has led to the development of product lines that offer non-drug treatments for prevalent conditions such as hypertension and heart failure. The company's flagship product, RESPeRATE, is the only FDA-cleared medical device shown to effectively reduce high blood pressure without side effects. Additionally, InterCure's heart failure treatment, InTone™, has successfully completed phase 2a clinical trials and is awaiting regulatory approval for market launch. With a strong management team and an esteemed Scientific Advisory Board, InterCure aims to lead the market in patient-focused medical devices that address significant health challenges without reliance on pharmaceuticals.

TouchSpin Gaming AG

Seed Round in 2014
TouchSpin Gaming has created a patented, multiplayer slot platform called TouchSpin Casino. Our first release on the platform is a social casino game called Texas Reels. This is a social, multiplayer slot game for the free to play casual games audience and hybridizes poker and slots. Texas Reels is based on our patented mutliplayer slot mechanic, that let’s you bet against other players sitting with you at the table. All bets go into the pot, like poker, and the winner takes all. TouchSpin Gaming is re-imagining the social casino platform. With revolutionary new slots interfaces, fast and easy game play, powerups and complete meta-game, we’ve created a thrilling new casino game experience, especially for Millienials. The TouchSpin Casino team is managed by technology and gaming professionals who are passionate about creating the next big thing in the casino slot experience. We have put our many years of industry experience into the development of what we believe is the multiplayer casino platform that will redefine the slots category.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.